[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kadhem et al., 2018 - Google Patents

Molecular detection of high risk human papilloma virus type 31/33 in uterine cervical tissues.

Kadhem et al., 2018

View PDF
Document ID
10384100268589199718
Author
Kadhem E
Al-Thahab A
Publication year
Publication venue
Biochemical & Cellular Archives

External Links

Snippet

Human papillomavirus (HPV) is a DNA virus. It is the main etiological factor for progress of cervical precancerous and cancerous lesions. In order to develop a cancer from dysplasia to invasive carcinoma, a series of cellular changes should occur. As genital HPV carries …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Similar Documents

Publication Publication Date Title
Tsoumpou et al. High-risk human papillomavirus DNA test and p16INK4a in the triage of LSIL: a prospective diagnostic study
Abu-Lubad et al. Human papillomavirus as an independent risk factor of invasive cervical and endometrial carcinomas in Jordan
Smith et al. Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay
CN101781686A (en) Fluorescent PCR (Polymerase Chain Reaction) kit for quantitively detecting HPV16/18 type infection
Doosti et al. Lack of evidence for a relationship between high risk human papillomaviruses and breast cancer in Iranian patients
Van Aardt et al. Unique human papillomavirus–type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection
Chujan et al. CCNA1 promoter methylation: a potential marker for grading Papanicolaou smear cervical squamous intraepithelial lesions
Bruno et al. A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up
Celewicz et al. Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer
Hernádi et al. Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions
Borsetto et al. Surveillance of HPV-positive head and neck squamous cell carcinoma with circulating and salivary DNA biomarkers
Zhang et al. Application Value of Detection of High-Risk HPV Infection in Early Cervical Cancer Patients in Disease Diagnosis and Prognosis Evaluation.
Khunamornpong et al. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand
Dixit et al. Laboratory diagnosis of human papillomavirus virus infection in female genital tract
Joharinia et al. Association of HPV16 and 18 genomic copies with histological grades of cervical lesions
González-Bosquet et al. Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2–3)
Calderón et al. Effectiveness of diagnostic testing for Cervical Cancer and Human Papilloma Virus
Kerkar et al. Human papillomavirus infection in asymptomatic population
Téllez et al. Persistent infection with high-risk human papilloma viruses: cohort study, Mérida, Venezuela
Frega et al. Expression of E6/E7 HPV-DNA, HPV-mRNA and colposcopic features in management of CIN2/3 during pregnancy
Kadhem et al. Molecular detection of high risk human papilloma virus type 31/33 in uterine cervical tissues.
Kim et al. Comparison of FFPE histological versus LBP cytological samples for HPV detection and typing in cervical cancer
Mastutik et al. p16INK4A Expression in Condyloma Acuminata Lesions associated with high-risk human Papillomavirus infection
Khasawneh et al. Prevalence and Genotype Distribution of Human Papillomavirus Among a Subpopulation of Jordanian Women
SheikhHaroon Role of Pap smear in early diagnosis of cervical cancer-A Case Study of women in Saudi Arabia